InvestorsHub Logo
Followers 29
Posts 2139
Boards Moderated 0
Alias Born 05/03/2020

Re: None

Monday, 05/17/2021 3:19:12 PM

Monday, May 17, 2021 3:19:12 PM

Post# of 232957
https://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab

Not a short attack.
Interesting line from FDA:

"However, as noted above, such analyses may inform the design of future clinical trials investigating leronlimab for the treatment of COVID-19.

If CytoDyn plans further studies of leronlimab to determine whether the drug can provide clinical benefit to individuals with COVID-19, FDA will continue to provide advice to the company on their development program.

FDA recognizes the critical unmet medical need for new, effective treatments for COVID-19, especially for severe forms of the disease. We are committed to working with sponsors of novel therapies to facilitate development and approval of new treatments."

I believe this may be due to public outcry to get LL to be approved from LL and this was their 'official' public response.

GLTU/A.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News